Electric shock treatment device and use method thereof

Abstract

The invention discloses an electric shock treatment device and a use method thereof, and the device comprises management software which is used for receiving and storing treatment process data and carrying out the evaluation of a treatment effect; the host controller is used for receiving the treatment scheme given by the management software, acquiring a biological point signal and sending the biological point signal to the management software for analysis and processing; the authentication module is used for acquiring and verifying identities of a therapist and a patient; a brain electrode; a trunk electrode; according to the invention, safety confirmation is carried out based on the patient medical record information and the identity tag, and safety operation hidden dangers are eliminated; on the basis of medical records and treatment history of a patient, treatment parameters are automatically generated, a therapist is assisted in quickly setting the treatment parameters, the problem that operation is tedious in the electroshock treatment process is solved, and meanwhile, the treatment efficiency is improved based on real-time monitoring data and historical treatment data of electroencephalogram, electrocardio and myoelectricity. And electroencephalogram / electrocardio / myoelectricity characteristic changes before and after treatment, epileptic seizure induction characteristic parameters and the like are automatically analyzed, so that a therapist can evaluate the clinical effect of a treatment scheme in time.

Description

Technical Field

[0001] The present invention relates to the field of biomedical engineering and medical equipment technology, and in particular to an electric shock therapy device and a method for using the same. Background Art

[0002] Since its creation in Italy in 1938, electroconvulsive therapy (ECT) has a history of more than 80 years. It has now become the most effective non-drug treatment in the field of psychiatry, with an effective rate of over 80% in treating depression. The principle of electroconvulsive therapy is to use direct current pulses to stimulate the patient's brain, inducing systemic convulsions, in order to achieve a treatment method for controlling mental symptoms. MECT is an improvement on the traditional electroconvulsive therapy (ECT) process, which is to first use intravenous anesthetics and muscle relaxants to make the patient lose consciousness, and then perform ECT treatment. It can eliminate the patient's painful feelings during the treatment process, reduce the fear of treatment, shorten the brain hypoxia time, etc. It has the characteristics of a wide range of applications, high safety, and few complications. It has been widely used to treat psychiatric diseases such as depression and schizophrenia.

[0003] At present, the electroconvulsive therapy equipment used in my country's medical clinical field relies on imports, the setting of treatment parameters depends on the therapist's experience, the operation process is cumbersome, and there is a lack of safe operation confirmation and dynamic adjustment of treatment parameters. The process of connecting treatment data to the hospital information management system is complicated, and the patient treatment and follow-up management process is time-consuming and labor-intensive. Summary of the invention

[0004] The main purpose of the present invention is to provide an electric shock therapy device and a method of using the same, aiming to solve the existing technical problems.

[0005] To achieve the above object, the present invention provides an electric shock therapy device, comprising:

[0006] Management software, used to receive and store treatment process data, evaluate treatment effects, and interact with hospital information systems;

[0007] The host controller is used to receive the treatment plan given by the management software, drive the two-phase rectangular pulse wave isolation output required for treatment, control the output power, obtain the biological point signal, and send it to the management software for analysis and processing;

[0008] Authentication module, used to obtain and verify the identity of therapists and patients;

[0009] The brain electrode is composed of a treatment electrode and an EEG electrode. The treatment electrode is used to output a biphasic rectangular pulse wave required for treatment, and the EEG electrode is used to obtain EEG signals.

[0010] The trunk electrode, which consists of an ECG electrode and a surface EMG electrode, is used to obtain ECG and EMG signals.

[0011] Furthermore, the management software includes:

[0012] The device management module uses the file interface unit to obtain the identity information of the therapist and the patient from the hospital information system, uses the identity authentication unit to compare and verify the identity information of the therapist and the patient collected by the authentication module, and decides whether to allow the host controller to run based on whether the therapist's identity authentication is passed. The acquisition configuration and device information unit interact with the host controller for instructions and status.

[0013] The treatment plan module is used to obtain the patient's medical record information, treatment history, recent treatment medication and physical examination data, and analyze and evaluate them through the risk identification unit. For patients without treatment contraindications, the treatment plan is generated through the plan reasoning unit;

[0014] A real-time display module is used to dynamically display the acquired treatment process data through a real-time curve unit;

[0015] The efficacy evaluation module is used to obtain treatment process data and analysis indicators, use the evaluation model to perform efficacy analysis, and generate treatment reports.

[0016] Furthermore, the treatment plan module includes:

[0017] Patient information module, used to provide patient's physical information data;

[0018] Medical history module, used to provide the patient's past medical history data;

[0019] Risk identification reasoning module, used to identify risks and provide treatment plans based on the patient's medical history;

[0020] Database for providing treatment plan information.

[0021] Furthermore, the parameters of the treatment plan include pulse frequency, pulse width, and treatment time, which are equivalent to energy percentage after calculation.

[0022] Furthermore, the database stores expert consensus, diagnosis and treatment guidelines, treatment procedures and contraindication information.

[0023] Furthermore, the patient information includes age, height, weight, gender, heart rate, blood pressure, and respiratory rate.

[0024] Furthermore, the host controller includes:

[0025] A waveform control module generates rectangular pulses according to a given treatment plan;

[0026] Impedance monitoring module, used to detect the contact impedance between the treatment electrode and the brain, and monitor the current and voltage output during treatment;

[0027] Constant current control module, generating constant DC output required for treatment;

[0028] The waveform driving module drives the output current of the constant current control module and the rectangular pulse generated by the waveform control module in combination to output a high-voltage DC two-phase pulse wave;

[0029] The electrical isolation module isolates the high-voltage DC biphasic pulse wave output by the waveform driving module and then applies it to the human body through the head electrodes.

[0030] Furthermore, the host controller further includes:

[0031] Communication interface module, used for data interaction among management software, interactive panel module, waveform control module, and bioelectric acquisition module;

[0032] The power management module is used for power supply management of various circuits of the host controller;

[0033] The interactive panel module is used to indicate the operating status of the host controller and receive control operations from the therapist.

[0034] An electric shock therapy method, using the electric shock therapy device as described above, specifically includes the following steps:

[0035] Connect the power supply and start the device; the management software establishes a data connection with the hospital information system;

[0036] The host controller runs a self-test program to check the integrity of the internal circuit signal. After the check is correct, it waits for the authentication module to verify the therapist's identity. If the verification is passed, it proceeds to the next step, otherwise it remains in the waiting state.

[0037] Standby;

[0038] Connect electrodes, set treatment parameters, and the therapist connects the patient's treatment electrodes and EEG / ECG / EMG electrodes. The management software uses the authentication module to obtain the patient's identity. After verification and confirmation that the treatment risk is controllable, the treatment plan is sent to the host controller for the therapist to review and confirm.

[0039] Adjust electrodes. The therapist checks and adjusts the patient's treatment electrodes;

[0040] Static impedance test: After checking and confirming the electrodes, the therapist presses the impedance measurement button to monitor and confirm that the impedance between the electrodes is within the predetermined range before proceeding to the next step. Otherwise, the therapist returns to adjust the electrodes.

[0041] EEG baseline test: The therapist checks and confirms the patient's anesthesia status. The device monitors the patient's EEG baseline and moves to the next step after the EEG waveform stabilizes.

[0042] Therapeutic waveform output: After the patient's EEG waveform is stable, the therapist is prompted to start treatment; the therapist presses the treatment button, and the host controller outputs the therapeutic waveform according to the treatment plan given by the management software; after the treatment waveform ends, the EEG, ECG and EMG are continuously monitored;

[0043] EEG data analysis: The management software analyzes EEG data, identifies whether a seizure is successfully induced, and stores data on the entire treatment process;

[0044] Report output: after the treatment is completed, a treatment report is generated; the system enters standby mode and starts the treatment process for the next patient.

[0045] The beneficial effects of the present invention are embodied in:

[0046] In the present invention, safety confirmation is performed based on the patient's medical record information and identity tags to eliminate safety operation hazards; treatment parameters are automatically generated based on the patient's medical record and treatment history to assist therapists in quickly setting treatment parameters, thus solving the problem of cumbersome operation during the electroconvulsive therapy process; at the same time, based on real-time monitoring data of EEG, ECG and EMG and historical treatment data, changes in EEG / ECG / EMG characteristics before and after treatment, characteristic parameters of induced epileptic seizures, etc. are automatically analyzed, allowing therapists to promptly evaluate the clinical effect of the treatment plan. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 is a schematic diagram of the structure of a device according to an embodiment of the present invention;

[0048] Figure 2 A schematic diagram of the system architecture of an embodiment of the present invention;

[0049] Figure 3 This is a functional diagram of the management software of an embodiment of the present invention;

[0050] Figure 4 A schematic diagram of a host controller according to an embodiment of the present invention;

[0051] Figure 5 A schematic diagram of reasoning for a solution of an embodiment of the present invention;

[0052] Figure 6 The figure is a flowchart of the method of using an embodiment of the present invention.

[0053] Description of reference numerals:

[0054] 100. Management software; 101. Equipment management module; 102. Treatment plan module; 1021. Patient information module; 1022. Medical history module; 1023. Risk identification and reasoning module; 1024. Database; 103. Real-time display module; 104. Efficacy evaluation module;

[0055] 200, host controller; 201, communication interface module; 202, power management module; 203, interactive panel module; 204, waveform control module; 205, impedance monitoring module; 206, constant current control module; 207, waveform driving module; 208, electrical isolation module; 209, bioelectric acquisition module; 210, simulation module;

[0056] 300, authentication module;

[0057] 400, brain electrodes;

[0058] 500. Trunk electrodes. DETAILED DESCRIPTION

[0059] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. In the absence of conflict, the embodiments in this application and the features in the embodiments can be combined with each other. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0060] Safety confirmation is performed based on the patient's medical record information and identity tags, and the treatment parameters are automatically adjusted according to the treatment history. The EEG, ECG and EMG data of the treatment process are monitored in real time. The changes in EEG / ECG / EMG characteristics before and after treatment and the characteristic parameters of induced epileptic seizures are automatically analyzed to evaluate the treatment effect. The treatment process data is transmitted to the medical information management system to provide a reference for the next adjustment of treatment parameters.

[0061] See also Figure 1 and 2 The present invention provides an electric shock therapy device, comprising:

[0062] Management software 100, used to use authentication module 300 to implement therapist and patient identity verification, evaluate treatment risks, generate treatment plans, control host controller 200 operation parameter configuration, receive and store treatment process data and evaluate treatment effects, and implement data interaction with hospital information systems, etc.;

[0063] The host controller 200 is used to receive the treatment plan given by the management software 100, drive the biphasic rectangular pulse wave isolation output required for treatment, control the output power, obtain the biological point signal sensed by the brain electrode 400 and the trunk electrode 500, and send it to the management software 100 for analysis and processing;

[0064] The authentication module 300 uses a code scanning, face recognition or other input methods to obtain the identity of the therapist and patient and sends it to the management software 100 for identity authentication;

[0065] The brain electrode 400 is composed of a treatment electrode and an EEG electrode, wherein the treatment electrode is used to output a biphasic rectangular pulse wave required for treatment, and the EEG electrode is used to obtain an EEG signal;

[0066] The trunk electrode 500 is composed of an electrocardiogram electrode and a surface electromyography electrode, and is used to obtain electrocardiogram and electromyography signals.

[0067] The present invention performs safety confirmation based on the patient's medical record information and identity tags, eliminating hidden dangers in safe operations; based on the patient's medical record and treatment history, it automatically generates treatment parameters to assist therapists in quickly setting treatment parameters, solving the problem of cumbersome operations during the electroconvulsive therapy process; at the same time, based on real-time monitoring data of EEG, ECG and EMG and historical treatment data, it automatically analyzes changes in EEG / ECG / EMG characteristics before and after treatment, characteristic parameters of induced epileptic seizures, etc., so that therapists can promptly evaluate the clinical effect of the treatment plan.

[0068] In one embodiment, see Figure 3 ,The management software 100 includes, a device management module 101, which uses the file interface unit to obtain the identity information of the therapist and the patient from the hospital information system, uses the identity authentication unit to compare and verify the identity information of the therapist and the patient collected by the authentication module 300, and decides whether to allow the host controller 200 to run according to whether the therapist's identity authentication is passed, and uses the collection configuration and device information unit to interact with the host controller 200 for instructions and status;

[0069] The treatment plan module 102 is used to obtain the patient's medical record information, treatment history, recent treatment medication and physical examination data, analyze and evaluate them through the risk identification unit, and generate a treatment plan for patients without treatment contraindications through the plan reasoning unit, which is transmitted to the host controller 200 for operation control;

[0070] The real-time display module 103 and the risk warning unit obtain the risk assessment results from the treatment plan module 102 for sound and light indication; the data receiving unit obtains the treatment process data from the host controller 200 and dynamically displays it through the real-time curve unit; the treatment process data and the analysis indicators of the parameter analysis unit are used for storage and reporting by the efficacy evaluation module 104;

[0071] The efficacy evaluation module 104 obtains the treatment process data and analysis indicators from the real-time display module 103, uses the evaluation model to perform efficacy analysis, and generates a treatment report; at the same time, the efficacy analysis results are fed back to the hospital information system through the file interface unit of the equipment management module 101 for the management of the entire treatment process and the optimization and adjustment of the treatment plan.

[0072] In one embodiment, see Figure 5,The treatment plan module 102 includes, a patient information module 1021, for providing the patient's physical information data;

[0073] The medical history module 1022 is used to provide the patient's past medical history data;

[0074] Risk identification and reasoning module 1023, used to identify risks and provide treatment plans based on the patient's medical history;

[0075] Database 1024 is used to provide treatment plan information.

[0076] Specifically, the parameters of the treatment plan include pulse frequency, pulse width, and treatment time, which are equivalent to energy percentage after calculation.

[0077] Specifically, database 1024 stores expert consensus, diagnosis and treatment guidelines, treatment procedures, and contraindication information.

[0078] Specifically, patient information includes age, height, weight, gender, heart rate, blood pressure, and respiratory rate.

[0079] In one embodiment, see Figure 4 ,The host controller 200 includes a waveform control module 204, which generates rectangular pulses according to a given treatment plan;

[0080] Impedance monitoring module 205, used to detect the contact impedance between the treatment electrode and the brain, and monitor the current and voltage output during treatment;

[0081] A constant current control module 206, generating a constant DC output required for treatment;

[0082] The waveform driving module 207 drives the output current of the constant current control module 206 and the rectangular pulse generated by the waveform control module 204 to output a high-voltage DC biphasic pulse wave;

[0083] The electrical isolation module 208 isolates and outputs the high-voltage DC biphasic pulse wave output by the waveform driving module 207, and then applies it to the human body through the head electrodes.

[0084] The bioelectric acquisition module 209 is used to obtain the head electroencephalogram signal, chest electrocardiogram signal and limb end electromyography signal, and transmit them to the management software 100 through the communication interface module 201 for treatment process monitoring and efficacy evaluation.

[0085] The simulation module 210 simulates a human body trunk signal.

[0086] In one embodiment, the host controller 200 further includes:

[0087] The communication interface module 201 is used for data interaction among the management software 100, the interactive panel module 203, the waveform control module 204, and the bioelectric acquisition module;

[0088] The power management module 202 is used for power supply management of various circuits of the host controller 200;

[0089] The interactive panel module 203 is used to indicate the operating status of the host controller 200 and receive control operations from the therapist.

[0090] The present invention also provides an electric shock treatment method, please refer to Figure 6 , using the above-mentioned electric shock therapy device, specifically including the following steps,

[0091] 601: Turn on the power supply and start the device; the management software 100 establishes a data connection with the hospital information system;

[0092] 602: The host controller 200 runs a self-check program to check the integrity of the internal circuit signal; after the check is correct, it waits for the authentication module 300 to verify the therapist's identity; if the verification is passed, it proceeds to the next step, otherwise it remains in the waiting state;

[0093] 603: Standby;

[0094] 604: Connect electrodes and set treatment parameters. The therapist connects the patient's treatment electrodes and EEG / ECG / EMG electrodes. The management software 100 obtains the patient's identity through the authentication module 300. After verification and confirmation that the treatment risk is controllable, the treatment plan is sent to the host controller 200 for the therapist to review and confirm.

[0095] 605: Adjust electrodes. The therapist checks and adjusts the patient's treatment electrodes;

[0096] 606: Static impedance test: after checking and confirming the electrodes, the therapist presses the impedance measurement button to monitor and confirm that the impedance between the electrodes is within the predetermined range, and then proceeds to the next step; otherwise, the therapist returns to adjust the electrodes;

[0097] 607: EEG baseline test: The therapist checks and confirms the patient's anesthesia status. The device monitors the patient's EEG baseline. When the EEG waveform stabilizes, proceed to the next step.

[0098] 608: Output of treatment waveform. After the patient's EEG waveform is stable, the therapist is prompted to start treatment. The therapist presses the treatment button, and the host controller 200 outputs the treatment waveform according to the treatment plan given by the management software 100. After the treatment waveform ends, the EEG, ECG and EMG are continuously monitored.

[0099] 609: EEG data analysis, the management software 100 analyzes the EEG data, identifies whether the spasm attack is successfully induced, and stores the data of the entire treatment process;

[0100] 610: Report output. After the treatment is completed, a treatment report is generated; the system enters standby mode and starts the treatment process for the next patient.

[0101] It should be noted that if the embodiments of the present invention involve directional indications such as up, down, left, right, front, back, etc., then the directional indications are only used to explain the relative position relationship, movement status, etc. between the components in a certain specific posture as shown in the accompanying drawings. If the specific posture changes, the directional indication will also change accordingly.

[0102] In addition, if there are descriptions involving "first", "second", etc. in the embodiments of the present invention, the descriptions of "first", "second", etc. are only used for descriptive purposes and cannot be understood as indicating or implying their relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In addition, the meaning of "and / or" appearing in the full text includes three parallel schemes. Taking "A and / or B" as an example, it includes scheme A, or scheme B, or schemes that A and B meet at the same time. In addition, "multiple" refers to more than two. In addition, the technical solutions between the various embodiments can be combined with each other, but it must be based on the ability of ordinary technicians in this field to implement. When the combination of technical solutions is contradictory or cannot be implemented, it should be deemed that such a combination of technical solutions does not exist.

[0103] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An electric shock therapy device, characterized in that ,include: Management software (100), used to receive and store treatment process data and evaluate treatment effects, and to exchange data with the hospital information system; The host controller (200) is used to receive the treatment plan given by the management software (100), drive the two-phase rectangular pulse wave isolation output required for treatment, control the output power, obtain the biological point signal, and send it to the management software (100) for analysis and processing; The authentication module (300) is used to obtain and verify the identity of the therapist and the patient; The brain electrode (400) is composed of a treatment electrode and an electroencephalogram electrode, wherein the treatment electrode is used to output a biphasic rectangular pulse wave required for treatment, and the electroencephalogram electrode is used to obtain an electroencephalogram signal; The trunk electrode (500) is composed of an electrocardiogram electrode and a surface electromyography electrode, and is used to obtain electrocardiogram and electromyography signals.

2. An electric shock therapy device as claimed in claim 1, characterized in that: The management software (100) includes: The device management module (101) uses the file interface unit to obtain the identity information of the therapist and the patient from the hospital information system, uses the identity authentication unit to compare and verify the identity information of the therapist and the patient collected by the authentication module (300), determines whether to allow the host controller (200) to run according to whether the therapist's identity authentication is passed, and uses the collection configuration and device information unit to exchange instructions and status with the host controller (200); The treatment plan module (102) is used to obtain the patient's medical record information, treatment history, recent treatment medication and physical examination data, analyze and evaluate them through the risk identification unit, and generate a treatment plan for patients without treatment contraindications through the plan reasoning unit; A real-time display module (103), used for dynamically displaying the acquired treatment process data through a real-time curve unit; The efficacy evaluation module (104) is used to obtain treatment process data and analysis indicators, use the evaluation model to perform efficacy analysis, and generate a treatment report.

3. An electroconvulsive therapy device as claimed in claim 2, characterized in that: The treatment plan module (102) includes: A patient information module (1021), used to provide patient's physical information data; A medical history module (1022), used to provide the patient's past medical history data; A risk identification reasoning module (1023), used to identify risks and provide treatment plans based on the patient's medical history; The database (1024) is used to provide treatment plan information.

4. An electroconvulsive therapy device as claimed in claim 3, characterized in that: The parameters of the treatment plan include pulse frequency, pulse width, and treatment time, which are equivalent to energy percentage after calculation.

5. An electric shock therapy device as claimed in claim 3, characterized in that: The database (1024) stores expert consensus, diagnosis and treatment guidelines, treatment procedures and contraindication information.

6. An electroconvulsive therapy device as claimed in claim 3, characterized in that: The patient information includes age, height, weight, gender, heart rate, blood pressure, and respiratory rate.

7. An electric shock therapy device as claimed in claim 1, characterized in that: The host controller (200) comprises: A waveform control module (204) generates rectangular pulses according to a given treatment plan; An impedance monitoring module (205) for detecting the contact impedance between the treatment electrode and the brain and monitoring the current and voltage output during treatment; A constant current control module (206) for generating a constant DC output required for treatment; A waveform driving module (207) drives the output current of the constant current control module (206) and the rectangular pulse generated by the waveform control module (204) in combination to output a high-voltage direct current biphasic pulse wave; The electrical isolation module (208) isolates and outputs the high-voltage direct current biphasic pulse wave output by the waveform driving module (207), and then applies the pulse to the human body via the head electrodes.

8. An electric shock therapy device as claimed in claim 7, characterized in that: The host controller (200) further includes, A communication interface module (201) is used for data interaction among the management software (100), the interactive panel module (203), the waveform control module (204), and the bioelectric acquisition module; A power management module (202), used for power supply management of various circuits of the host controller (200); The interactive panel module (203) is used to indicate the operating status of the host controller (200) and receive control operations from the therapist.

9. An electroconvulsive therapy method, using the electroconvulsive therapy device according to any one of claims 1 to 8, characterized in that: The specific steps include: The power supply is turned on and the device is turned on; the management software (100) establishes a data connection with the hospital information system; The host controller (200) runs a self-checking program to check the integrity of the internal circuit signal; after the check is correct, it waits for the authentication module (300) to verify the identity of the therapist; if the verification is passed, it proceeds to the next step, otherwise it remains in the waiting state; Standby; Connect electrodes, set treatment parameters, and the therapist connects the patient's treatment electrodes, EEG / ECG / EMG electrodes; The management software (100) uses the authentication module (300) to obtain the patient's identity, and after verification and confirmation that the treatment risk is controllable, sends the treatment plan to the host controller (200) for review and confirmation by the therapist; Adjust electrodes. The therapist checks and adjusts the patient's treatment electrodes; Static impedance test: After checking and confirming the electrodes, the therapist presses the impedance measurement button to monitor and confirm that the impedance between the electrodes is within the predetermined range before proceeding to the next step. Otherwise, the therapist returns to adjust the electrodes. EEG baseline test: The therapist checks and confirms the patient's anesthesia status. The device monitors the patient's EEG baseline and moves to the next step after the EEG waveform stabilizes. The treatment waveform is output, and after the patient's EEG waveform is stable, the therapist is prompted to start treatment; the therapist presses the treatment button, and the host controller (200) outputs the treatment waveform according to the treatment plan given by the management software (100); after the treatment waveform ends, the EEG, ECG and EMG are continuously monitored; EEG data analysis, management software (100) analyzes EEG data, identifies whether a spasm attack is successfully induced, and stores data of the entire treatment process; Report output: after the treatment is completed, a treatment report will be generated; Enter standby mode and start the treatment process for the next patient.

Images